Adani Ports breaks out at record Rs 1,747 as 500 MMT milestone meets Hormuz reroute trade (NSE: ADANIPORTS)
Read More Pharma Industry News AstraZeneca acquires oral PCSK9 inhibitors from Dogma Therapeutics Pharma giant AstraZeneca has signed a deal to acquire a preclinical oral PCSK9 inhibitor asset from Dogma Therapeutics,… bypharmanewsdailySeptember 19, 2020
